The groundbreaking treatment of the medication represents a exciting advance in the handling of type 2 diabetes. Unlike existing drugs, tirzepatide targets two pathways – the GLP-1 hormone and the GIP hormone – https://tirzepatidepeptide172334.blogdun.com/42732436/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment